Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Tax Provisions (2009 - 2026)

Charles River Laboratories International (CRL) posted Tax Provisions of $53.9 million for Q2 2026, up 456.21% on a QoQ basis from -$15.1 million in Q1 2026, and up 188.01% year-over-year from $18.7 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Tax Provisions (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Tax Provisions for 18 years, with the latest figure at $53.9 million in Q2 2026.

  • On a quarterly basis, Tax Provisions rose 188.01% year-over-year to $53.9 million in Q2 2026; TTM through Jun 2026 was $52.6 million, a 12.62% increase from a year earlier, with the FY2025 full-year figure at $42.7 million, down 37.1% from the prior year.
  • Tax Provisions was $53.9 million for Q2 2026 at Charles River Laboratories International, up from -$15.1 million in the prior quarter.
  • The five-year high for Tax Provisions was $55.8 million in Q4 2022, with the low at -$17.8 million in Q4 2025.
  • Average Tax Provisions over 5 years is $21.1 million, with a median of $24.7 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Tax Provisions surged 559.91% in 2022, then sank 485.05% in 2025.
  • Over 5 years, Tax Provisions stood at $55.8 million in 2022, then slumped by 64.61% to $19.8 million in 2023, then plunged by 115.41% to -$3.0 million in 2024, then tumbled by 485.05% to -$17.8 million in 2025, then surged by 402.82% to $53.9 million in 2026.
  • The last three Tax Provisions figures came in at $53.9 million (Q2 2026), -$15.1 million (Q1 2026), and -$17.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 60.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 30.30 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -19.62 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 53.93 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 12.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 128,000.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 11,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -113.32 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 53.93 Mn
Mar 28, 2026 -15.14 Mn
Dec 27, 2025 -17.81 Mn
Sep 27, 2025 31.64 Mn
Jun 28, 2025 18.73 Mn
Mar 29, 2025 10.10 Mn
Dec 28, 2024 -3.04 Mn
Sep 28, 2024 20.95 Mn
Jun 29, 2024 25.39 Mn
Mar 30, 2024 24.53 Mn
Dec 30, 2023 19.75 Mn
Sep 30, 2023 24.85 Mn
Jul 1, 2023 29.22 Mn
Apr 1, 2023 27.09 Mn
Dec 31, 2022 55.82 Mn
Sep 24, 2022 25.50 Mn
Jun 25, 2022 33.45 Mn
Mar 26, 2022 15.62 Mn
Dec 25, 2021 23.82 Mn
Sep 25, 2021 18.11 Mn